MBX BiosciencesMBX
那斯達克 · USD
61.78
-1.21
(-1.92%)
盤中 09/10 01:09 (UTC+8)
09/10 01:09 (UTC+8)
MBX BiosciencesMBX
61.78
-1.21
(-1.92%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 40,931 | 27,265 | 25,795 | 23,926 | 21,805 | 26,529 | 18,610 | 19,612 | 16,658 | 13,314 |
研發費用 | 30,985 | 18,474 | 19,759 | 19,270 | 17,725 | 22,405 | 15,223 | 16,747 | 14,396 | 11,049 |
推銷及管理費用 | 9,946 | 8,791 | 6,036 | 4,656 | 4,080 | 4,124 | 3,387 | 2,865 | 2,262 | 2,265 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -40,931 | -27,265 | -25,795 | -23,926 | -21,805 | -26,529 | -18,610 | -19,612 | -16,658 | -13,314 |
其他收入及費用 | 3,836 | 3,748 | 3,733 | 2,308 | 2,394 | 2,649 | 3,024 | 1,470 | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -37,095 | -23,517 | -22,062 | -21,618 | -19,411 | -23,880 | -15,586 | -18,142 | -15,857 | -12,337 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -37,095 | -23,517 | -22,062 | -21,618 | -19,411 | -23,880 | -15,586 | -18,142 | -15,857 | -12,337 |
基本每股稅後盈餘(元) | -0.78 | -0.50 | -0.49 | -0.63 | -0.58 | -0.71 | -0.47 | -2.78 | -0.50 | -0.39 |
稀釋每股稅後盈餘(元) | -0.79 | -0.50 | -0.45 | -0.63 | -0.59 | -0.71 | 9.60 | 7.51 | -0.50 | -0.39 |
基本平均股數(千股) | 47696.00 | 46576.00 | 44866.00 | 34198.00 | 33446.00 | 33412.00 | 33392.00 | 6515.00 | 31853.00 | 31853.00 |
稀釋平均股數(千股) | 47696.00 | 46576.00 | 44866.00 | 34198.00 | 33446.00 | 33412.00 | 33392.00 | 6515.00 | 31853.00 | 31853.00 |
還原基本每股稅後盈餘(元) | -0.78 | -0.50 | -0.49 | -0.63 | -0.58 | -0.71 | -0.47 | -2.78 | -0.50 | -0.39 |
還原稀釋每股稅後盈餘(元) | -0.79 | -0.50 | -0.45 | -0.63 | -0.59 | -0.71 | 9.60 | 7.51 | -0.50 | -0.39 |
還原基本平均股數(千股) | 47,696 | 46,576 | 44,866 | 34,198 | 33,446 | 33,412 | 33,392 | 6,515 | 31,853 | 31,853 |
還原稀釋平均股數(千股) | 47,696 | 46,576 | 44,866 | 34,198 | 33,446 | 33,412 | 33,392 | 6,515 | 31,853 | 31,853 |
EBITDA(千元) | -37,437 | -24,032 | -22,557 | -22,302 | -20,329 | -25,146 | -16,925 | -18,654 | -15,794 | -12,289 |